tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ATXS Stock Latest News

Zillow initiated, Electronic Arts upgraded: Wall Street’s top analyst calls
The FlyZillow initiated, Electronic Arts upgraded: Wall Street’s top analyst calls
22d ago
Z
EA
Astria Therapeutics initiated with an Outperform at JMP Securities
PremiumThe Fly
Astria Therapeutics initiated with an Outperform at JMP Securities
22d ago
ATXS
Astria initiates Phase 1a Trial of STAR-0310 trial, sees proof of concept in Q3
PremiumThe Fly
Astria initiates Phase 1a Trial of STAR-0310 trial, sees proof of concept in Q3
1M ago
ATXS
Astria Therapeutics designs ALPHA-ORBIT Phase 3 trial of navenibart in HAE
PremiumThe Fly
Astria Therapeutics designs ALPHA-ORBIT Phase 3 trial of navenibart in HAE
1M ago
ATXS
Astria Therapeutics Unveils Phase 3 Trial for Navenibart
PremiumCompany Announcements
Astria Therapeutics Unveils Phase 3 Trial for Navenibart
1M ago
8K
ATXS
Astria Therapeutics Expands Stock Incentive Plan
PremiumCompany AnnouncementsAstria Therapeutics Expands Stock Incentive Plan
2M ago
8K
ATXS
Astria Therapeutics price target raised to $32 from $28 at Oppenheimer
Premium
The Fly
Astria Therapeutics price target raised to $32 from $28 at Oppenheimer
2M ago
ATXS
Astria Therapeutics announces final results from ALPHA-STAR trial
Premium
The Fly
Astria Therapeutics announces final results from ALPHA-STAR trial
2M ago
ATXS
Astria Therapeutics announces FDA clearance for STAR-0310 IND application
PremiumThe Fly
Astria Therapeutics announces FDA clearance for STAR-0310 IND application
2M ago
ATXS
Astria Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Astria Therapeutics Reports Q3 2024 Financial Results
3M ago
ATXS
Astria Therapeutics price target raised to $28 from $26 at Oppenheimer
PremiumThe Fly
Astria Therapeutics price target raised to $28 from $26 at Oppenheimer
3M ago
ATXS
Astria Therapeutics reports Q3 EPS (42c), consensus (42c)
PremiumThe Fly
Astria Therapeutics reports Q3 EPS (42c), consensus (42c)
3M ago
ATXS
Is ATXS a Buy, Before Earnings?
PremiumPre-EarningsIs ATXS a Buy, Before Earnings?
4M ago
ATXS
EC grants Astria’s OMPD to navenibart for HAE
Premium
The Fly
EC grants Astria’s OMPD to navenibart for HAE
4M ago
ATXS
Astria Therapeutics gets ODD from FDA for navenibar to treat HAE
Premium
The Fly
Astria Therapeutics gets ODD from FDA for navenibar to treat HAE
5M ago
ATXS
Astria Therapeutics price target raised to $26 from $25 at Oppenheimer
PremiumThe Fly
Astria Therapeutics price target raised to $26 from $25 at Oppenheimer
6M ago
ATXS
Astria Therapeutics reports Q2 EPS (43c), consensus (38c)
PremiumThe Fly
Astria Therapeutics reports Q2 EPS (43c), consensus (38c)
6M ago
ATXS
Astria Therapeutics, Inc. (ATXS) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Astria Therapeutics, Inc. (ATXS) Q2 Earnings Cheat Sheet
7M ago
ATXS
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alphabet upgraded, Arm downgraded: Wall Street’s top analyst calls
7M ago
GD
ARM
Astria Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlyAstria Therapeutics initiated with a Buy at TD Cowen
7M ago
ATXS
Astria Therapeutics Shareholders Meeting Decisions and Elections
Premium
Company Announcements
Astria Therapeutics Shareholders Meeting Decisions and Elections
9M ago
8K
ATXS
Astria Therapeutics price target lowered to $25 from $29 at Oppenheimer
Premium
The Fly
Astria Therapeutics price target lowered to $25 from $29 at Oppenheimer
9M ago
ATXS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >